ART BioScience

Genetic Therapies for Duchenne Muscular Dystrophy

Active Pre-Funding Startup Rehovot Founded 2015-07

Website ↗

ART BioScience specializes in the use of novel messenger RNA technologies for the development of therapeutics that may potentially change the course of Duchenne Muscular Dystrophy. The company’s initial work began with lipids licensed from the laboratory of Professor Dan Peer. ART BioScience has optimized these lipids for effective muscle delivery based on…